iSpecimen (ISPC) Cash & Current Investments (2020 - 2026)

iSpecimen (ISPC) has reported Cash & Current Investments for 7 consecutive years, with $2.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Current Investments rose 260.23% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 260.23% YoY), while the FY2025 annual figure was $6.9 million, up 266.31% from the prior year.
• Cash & Current Investments came in at $2.8 million for Q1 2026 at iSpecimen, down from $6.9 million in the prior quarter.
• The five-year high for Cash & Current Investments was $26.1 million in Q1 2022, with the low at $588775.0 in Q2 2025.
• Average Cash & Current Investments over 5 years is $8.1 million, with a median of $5.0 million recorded in 2023.
• Across the five-year window, Cash & Current Investments plunged 76.81% in 2024 and jumped 266.31% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $15.3 million in 2022, then tumbled by 67.3% to $5.0 million in 2023, then plunged by 62.47% to $1.9 million in 2024, then surged by 266.31% to $6.9 million in 2025, then tumbled by 59.03% to $2.8 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $2.8 million, $6.9 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.